@article{886393d635d64c80b65e92cd46cbf2e6,
title = "Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors",
keywords = "breast cancer, cancer epitopes, cancer vaccines, checkpoint inhibitors, immunotherapy, melanoma, oncolytic vaccines, oncolytic viruses, therapeutic antibodies, therapeutic vaccination, NEGATIVE BREAST-CANCER, T-CELL RESPONSES, SUPPRESSOR-CELLS, PD-1/PD-L1 INTERACTIONS, IMMUNOTHERAPY, RESISTANCE, COMBINATION, PATHWAYS, THERAPY, VIRUSES, 3122 Cancers, 317 Pharmacy",
author = "S. Feola and C. Capasso and M. Fusciello and B. Martins and S. T{\"a}htinen and M. Medeot and S. Carpi and F. Frascaro and E. Yl{\"o}smaki and K. Peltonen and L. Pastore and V. Cerullo",
year = "2018",
doi = "10.1080/2162402X.2018.1457596",
language = "English",
volume = "7",
journal = "OncoImmunology",
issn = "2162-402X",
publisher = "Landes Bioscience",
number = "8",
}